[
  {
    "drug_name": "PP-1",
    "brd_id": "BRD-K47598052-001-06-7",
    "sig_id": "CPC002_PC3_6H:BRD-K47598052-001-06-7:10",
    "score": -11.9913,
    "pvalue": 2.68608123957651e-07,
    "qvalue": 0.00383294839283436,
    "zscore": 1.824920134370834,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "SRC inhibitor",
    "target": "HCK | RET | SRC",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "GlyTouCan:G32632JB",
    "brd_id": "BRD-K40656405-001-01-5",
    "sig_id": "CPC002_PC3_6H:BRD-K40656405-001-01-5:10",
    "score": -9.0777,
    "pvalue": 1.19750034123877e-05,
    "qvalue": 0.0400531231230799,
    "zscore": 1.8444049709096937,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "tenidap",
    "brd_id": "BRD-A87479750-001-01-9",
    "sig_id": "CPC001_VCAP_24H:BRD-A87479750-001-01-9:10",
    "score": -8.8274,
    "pvalue": 1.64507050614965e-05,
    "qvalue": 0.0414257784104472,
    "zscore": 1.8452633128532923,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "cyclooxygenase inhibitor",
    "target": "ALOX5 | KCNJ4 | PTGS1",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K88378636-001-02-8",
    "brd_id": "BRD-K88378636-001-02-8",
    "sig_id": "ERG005_VCAP_6H:BRD-K88378636-001-02-8:20",
    "score": -7.7022,
    "pvalue": 2.19167492325571e-05,
    "qvalue": 0.0435657138716559,
    "zscore": 1.6530998735781135,
    "cell_line": "VCAP",
    "dose": "20",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "high"
  },
  {
    "drug_name": "BRD-K25373946-001-04-6",
    "brd_id": "BRD-K25373946-001-04-6",
    "sig_id": "CPC007_PC3_6H:BRD-K25373946-001-04-6:10",
    "score": -7.6479,
    "pvalue": 6.41786130517931e-05,
    "qvalue": 0.0957349706036802,
    "zscore": 1.8241342906452638,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "GANT-58",
    "brd_id": "BRD-K64451768-001-01-3",
    "sig_id": "CPC006_MCF7_24H:BRD-K64451768-001-01-3:10",
    "score": -7.2845,
    "pvalue": 9.57100021638624e-05,
    "qvalue": 0.0957349706036802,
    "zscore": 1.8125079177562782,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "GLI antagonist",
    "target": "DHH | GLI1 | IHH",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "mafenide",
    "brd_id": "BRD-K30649484-015-07-3",
    "sig_id": "CPC009_MCF7_24H:BRD-K30649484-015-07-3:10",
    "score": -7.0878,
    "pvalue": 0.000106542309382467,
    "qvalue": 0.0957349706036802,
    "zscore": 1.7842258308746552,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "carbonic anhydrase inhibitor",
    "target": "CA12 | CA14 | CA2 | CA4 | CA6 | CA9",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K66792149-001-01-8",
    "brd_id": "BRD-K66792149-001-01-8",
    "sig_id": "CPC006_PC3_24H:BRD-K66792149-001-01-8:11.1",
    "score": -7.0669,
    "pvalue": 0.000114886149389284,
    "qvalue": 0.0957349706036802,
    "zscore": 1.7937463246226915,
    "cell_line": "PC3",
    "dose": "11.1",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K32644160-001-16-4",
    "brd_id": "BRD-K32644160-001-16-4",
    "sig_id": "CPC007_PC3_24H:BRD-K32644160-001-16-4:10",
    "score": -6.9396,
    "pvalue": 0.000213645104230279,
    "qvalue": 0.122410114907044,
    "zscore": 1.890744162812788,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "Ro-28-1675",
    "brd_id": "BRD-K21672174-001-02-2",
    "sig_id": "CPC006_HCC15_6H:BRD-K21672174-001-02-2:160",
    "score": -6.9275,
    "pvalue": 0.000139145741936584,
    "qvalue": 0.0958041294275837,
    "zscore": 1.796313993867493,
    "cell_line": "HCC15",
    "dose": "160",
    "time": "6H",
    "moa": "glucokinase activator",
    "target": "GCK",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "(S)-2-((9-([1,1'-biphenyl]-4-ylmethyl)-2-((2,3-dihydro-1H-inden-5-yl)oxy)-9H-purin-6-yl)amino)-3-phenylpropan-1-ol",
    "brd_id": "BRD-K02526760-001-01-5",
    "sig_id": "CPC006_HT29_24H:BRD-K02526760-001-01-5:10",
    "score": -6.8179,
    "pvalue": 0.000258425134256442,
    "qvalue": 0.143674306134858,
    "zscore": 1.900362164854504,
    "cell_line": "HT29",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "Awl-II-38.3",
    "brd_id": "BRD-K68191783-001-01-2",
    "sig_id": "CPC013_PC3_24H:BRD-K68191783-001-01-2:10",
    "score": -6.6564,
    "pvalue": 0.000151690988440703,
    "qvalue": 0.0983899927902734,
    "zscore": 1.7429513832121164,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "Acetic acid [2-(4-acetamido-6-phenyl-1,3,5-triazin-2-yl)phenyl] ester",
    "brd_id": "BRD-K37549600-001-01-0",
    "sig_id": "CPC019_HT29_6H:BRD-K37549600-001-01-0:10",
    "score": -6.5439,
    "pvalue": 0.000123764107705904,
    "qvalue": 0.0957349706036802,
    "zscore": 1.6747335951872628,
    "cell_line": "HT29",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "RG 13022",
    "brd_id": "BRD-K82688027-001-01-5",
    "sig_id": "CPC001_VCAP_24H:BRD-K82688027-001-01-5:10",
    "score": -6.3527,
    "pvalue": 0.000427666808184289,
    "qvalue": 0.170634907488047,
    "zscore": 1.8856828052931467,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "YK-4-279",
    "brd_id": "BRD-A62182663-001-01-4",
    "sig_id": "ERG011_VCAP_24H:BRD-A62182663-001-01-4:2",
    "score": -6.2573,
    "pvalue": 0.000139145741936584,
    "qvalue": 0.0958041294275837,
    "zscore": 1.6225321560863204,
    "cell_line": "VCAP",
    "dose": "2",
    "time": "24H",
    "moa": "apoptosis inhibitor",
    "target": "EWSR1 | FLI1",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione",
    "brd_id": "BRD-A59985574-003-01-9",
    "sig_id": "CPC012_HCC515_6H:BRD-A59985574-003-01-9:10",
    "score": -6.24,
    "pvalue": 0.000344546233628498,
    "qvalue": 0.170634907488047,
    "zscore": 1.8020401999313411,
    "cell_line": "HCC515",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "N'-(2-aminophenyl)-N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]heptanediamide",
    "brd_id": "BRD-K86899078-001-01-2",
    "sig_id": "CPC019_PC3_24H:BRD-K86899078-001-01-2:10",
    "score": -6.1963,
    "pvalue": 0.000160562318903112,
    "qvalue": 0.102431627040414,
    "zscore": 1.6330257840394353,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K36153907-001-03-8",
    "brd_id": "BRD-K36153907-001-03-8",
    "sig_id": "CPC008_VCAP_24H:BRD-K36153907-001-03-8:10",
    "score": -6.1915,
    "pvalue": 0.000392683950490305,
    "qvalue": 0.170634907488047,
    "zscore": 1.8178444238585922,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "batimastat",
    "brd_id": "BRD-K82818427-001-01-4",
    "sig_id": "CPC006_HCC515_24H:BRD-K82818427-001-01-4:44.4",
    "score": -5.9743,
    "pvalue": 0.000512040326595464,
    "qvalue": 0.170634907488047,
    "zscore": 1.8155055384092886,
    "cell_line": "HCC515",
    "dose": "44.4",
    "time": "24H",
    "moa": "matrix metalloprotease inhibitor",
    "target": "ADAM28 | ADAMTS5 | MMP1 | MMP12 | MMP16 | MMP2 | MMP8",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "dovitinib",
    "brd_id": "BRD-K85402309-001-01-7",
    "sig_id": "CPC014_A375_6H:BRD-K85402309-001-01-7:10",
    "score": -5.962,
    "pvalue": 0.000433732406211222,
    "qvalue": 0.170634907488047,
    "zscore": 1.772946158076586,
    "cell_line": "A375",
    "dose": "10",
    "time": "6H",
    "moa": "EGFR inhibitor | FGFR inhibitor | FLT3 inhibitor | PDGFR tyrosine kinase receptor inhibitor | VEGFR inhibitor",
    "target": "CSF1R | EGFR | FGFR1 | FGFR2 | FGFR3 | FLT1 | FLT3 | FLT4 | INSR | KDR | KIT | PDGFRA | PDGFRB",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K10882151-001-06-8",
    "brd_id": "BRD-K10882151-001-06-8",
    "sig_id": "CPC006_A375_6H:BRD-K10882151-001-06-8:40",
    "score": -5.9584,
    "pvalue": 0.000540513787567681,
    "qvalue": 0.170634907488047,
    "zscore": 1.823707751786851,
    "cell_line": "A375",
    "dose": "40",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "selumetinib",
    "brd_id": "BRD-K57080016-001-04-3",
    "sig_id": "CPC006_HCC15_6H:BRD-K57080016-001-04-3:80",
    "score": -5.8764,
    "pvalue": 0.000547825816944285,
    "qvalue": 0.170634907488047,
    "zscore": 1.8018253676336426,
    "cell_line": "HCC15",
    "dose": "80",
    "time": "6H",
    "moa": "MEK inhibitor",
    "target": "MAP2K1 | MAP2K2",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-A02481876-001-09-9",
    "brd_id": "BRD-A02481876-001-09-9",
    "sig_id": "CPC006_PC3_6H:BRD-A02481876-001-09-9:60",
    "score": -5.7224,
    "pvalue": 0.000658738170001561,
    "qvalue": 0.170634907488047,
    "zscore": 1.7987583994836573,
    "cell_line": "PC3",
    "dose": "60",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "(4R,8S,9S,11S,12R,13S,19S)-12,19-Difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one",
    "brd_id": "BRD-A77824596-001-03-2",
    "sig_id": "CPC005_A549_24H:BRD-A77824596-001-03-2:10",
    "score": -5.7063,
    "pvalue": 0.000675941888116749,
    "qvalue": 0.170634907488047,
    "zscore": 1.8000370309276041,
    "cell_line": "A549",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "3-(1H-indazol-6-yl)-1-propan-2-yl-4-pyrazolo[3,4-d]pyrimidinamine",
    "brd_id": "BRD-K03618428-001-01-3",
    "sig_id": "CPC006_HCC515_24H:BRD-K03618428-001-01-3:22.2",
    "score": -5.6703,
    "pvalue": 0.00076739411869988,
    "qvalue": 0.170634907488047,
    "zscore": 1.8203377617684058,
    "cell_line": "HCC515",
    "dose": "22.2",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "7-Ethyl-10-hydroxy camptothecin, (rac)-",
    "brd_id": "BRD-A36630025-001-02-6",
    "sig_id": "CPC006_RMUGS_6H:BRD-A36630025-001-02-6:0.35",
    "score": -5.6036,
    "pvalue": 0.000720516692829789,
    "qvalue": 0.170634907488047,
    "zscore": 1.783259382731723,
    "cell_line": "RMUGS",
    "dose": "0.35",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "1-((3,4-Difluorophenyl)methyl)-2-oxo-N-((1R)-2-((2-oxo-2,3-dihydro-1H-benzimidazol-5-yl)oxy)-1-phenylethyl)-1,2-dihydropyridine-3-carboxamide",
    "brd_id": "BRD-K09186807-001-01-6",
    "sig_id": "CPC014_HT29_6H:BRD-K09186807-001-01-6:10",
    "score": -5.5877,
    "pvalue": 0.000593371843821855,
    "qvalue": 0.170634907488047,
    "zscore": 1.7317248152625722,
    "cell_line": "HT29",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "lovastatin",
    "brd_id": "BRD-K09416995-001-21-7",
    "sig_id": "CPC003_HA1E_24H:BRD-K09416995-001-21-7:10",
    "score": -5.5545,
    "pvalue": 0.000837051334357025,
    "qvalue": 0.170634907488047,
    "zscore": 1.8050219487244255,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "24H",
    "moa": "HMGCR inhibitor",
    "target": "CYP3A5 | HDAC2 | HMGCR | ITGAL | NR1I2",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "(7S,9S)-7-[[(4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione",
    "brd_id": "BRD-A52530684-001-01-1",
    "sig_id": "CPC018_A375_6H:BRD-A52530684-001-01-1:10",
    "score": -5.5051,
    "pvalue": 0.000585578481647285,
    "qvalue": 0.170634907488047,
    "zscore": 1.7030991322582887,
    "cell_line": "A375",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "Erythrosin(E)",
    "brd_id": "BRD-K14920963-304-01-9",
    "sig_id": "CPC004_HA1E_24H:BRD-K14920963-304-01-9:10",
    "score": -5.4486,
    "pvalue": 0.000879046448904508,
    "qvalue": 0.17314317705545,
    "zscore": 1.7829111307476084,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "YC-1",
    "brd_id": "BRD-K60476892-001-02-1",
    "sig_id": "CVD001_HUH7_6H:BRD-K60476892-001-02-1:16.4289",
    "score": -5.416,
    "pvalue": 0.000570236448321795,
    "qvalue": 0.170634907488047,
    "zscore": 1.6695814605516612,
    "cell_line": "HUH7",
    "dose": "16.4289",
    "time": "6H",
    "moa": "guanylyl cyclase activator",
    "target": "GUCY1A2 | GUCY1A3 | GUCY1B3 | HIF1A",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "Amberlite CG 400",
    "brd_id": "BRD-A51410489-003-02-8",
    "sig_id": "CPC016_MCF7_24H:BRD-A51410489-003-02-8:10",
    "score": -5.4145,
    "pvalue": 0.000633587223848704,
    "qvalue": 0.170634907488047,
    "zscore": 1.693000544405012,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K56653679-001-01-2",
    "brd_id": "BRD-K56653679-001-01-2",
    "sig_id": "CPC012_HA1E_6H:BRD-K56653679-001-01-2:10",
    "score": -5.3409,
    "pvalue": 0.000738986675476377,
    "qvalue": 0.170634907488047,
    "zscore": 1.70562307962057,
    "cell_line": "HA1E",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "ITK inhibitor",
    "brd_id": "BRD-A29901043-001-01-0",
    "sig_id": "CPC014_MCF7_6H:BRD-A29901043-001-01-0:10",
    "score": -5.3187,
    "pvalue": 0.000738986675476377,
    "qvalue": 0.170634907488047,
    "zscore": 1.6985321476647466,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-A74904029-001-05-7",
    "brd_id": "BRD-A74904029-001-05-7",
    "sig_id": "CPC014_MCF7_6H:BRD-A74904029-001-05-7:10",
    "score": -5.2894,
    "pvalue": 0.000748361487880463,
    "qvalue": 0.170634907488047,
    "zscore": 1.692121361034965,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "BRD-K63569039-001-04-0",
    "brd_id": "BRD-K63569039-001-04-0",
    "sig_id": "CPC007_VCAP_6H:BRD-K63569039-001-04-0:10",
    "score": -5.2861,
    "pvalue": 0.000933865211166065,
    "qvalue": 0.176113814206203,
    "zscore": 1.7447456780208073,
    "cell_line": "VCAP",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "CGP-60474",
    "brd_id": "BRD-K79090631-001-18-1",
    "sig_id": "LJP001_SKBR3_6H:BRD-K79090631-001-18-1:0.08",
    "score": -5.2293,
    "pvalue": 0.000641884450043951,
    "qvalue": 0.170634907488047,
    "zscore": 1.6379736716976838,
    "cell_line": "SKBR3",
    "dose": "0.08",
    "time": "6H",
    "moa": "CDK inhibitor",
    "target": "CDK1 | CDK2",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "(3S,3'S,4'R,5'S)-4'-[fluoro(dimethyl)silyl]-5'-(2-hydroxyethyl)-3'-methyl-5-(2-oxo-1-piperidinyl)-1-prop-2-enyl-2-spiro[indole-3,2'-oxolane]one",
    "brd_id": "BRD-K82971429-001-01-9",
    "sig_id": "CPC012_MCF7_24H:BRD-K82971429-001-01-9:10",
    "score": -5.1908,
    "pvalue": 0.000991350439370097,
    "qvalue": 0.182140433300405,
    "zscore": 1.7280924843852432,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "24H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "alvocidib",
    "brd_id": "BRD-K87909389-001-04-6",
    "sig_id": "LJP001_SKBR3_6H:BRD-K87909389-001-04-6:0.08",
    "score": -5.1894,
    "pvalue": 0.000667295954884253,
    "qvalue": 0.170634907488047,
    "zscore": 1.634107390510975,
    "cell_line": "SKBR3",
    "dose": "0.08",
    "time": "6H",
    "moa": "CDK inhibitor",
    "target": "BCL2 | BIRC5 | CCNT1 | CDK1 | CDK2 | CDK4 | CDK5 | CDK6 | CDK7 | CDK8 | CDK9 | EGFR | MCL1 | PYGM | XIAP",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "(1R,9S,12S,15R,16Z,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-12-[(2R)-1-[(1S,3R,4R)-4-dimethylphosphoryloxy-3-methoxycyclohexyl]propan-2-yl]-1,18-dihydroxy-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone",
    "brd_id": "BRD-K29733039-001-01-1",
    "sig_id": "CPC013_PC3_6H:BRD-K29733039-001-01-1:10",
    "score": -5.041,
    "pvalue": 0.00101511140490307,
    "qvalue": 0.18321523258115,
    "zscore": 1.6839953254783113,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "",
    "target": "",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "beclomethasone-dipropionate",
    "brd_id": "BRD-K97810537-001-09-4",
    "sig_id": "CPC020_A375_6H:BRD-K97810537-001-09-4:10",
    "score": -4.9384,
    "pvalue": 0.000945146059473972,
    "qvalue": 0.176684531266468,
    "zscore": 1.6327959273810266,
    "cell_line": "A375",
    "dose": "10",
    "time": "6H",
    "moa": "glucocorticoid receptor agonist",
    "target": "CYP3A5 | GPR97 | NR3C1",
    "phase": "",
    "confidence": "medium"
  },
  {
    "drug_name": "NSC-95397",
    "brd_id": "BRD-K68143200-001-04-2",
    "sig_id": "CPC003_PC3_24H:BRD-K68143200-001-04-2:10",
    "score": -4.6499,
    "pvalue": 0.00288738949090266,
    "qvalue": 0.292575571944643,
    "zscore": 1.831047193702424,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "CDC inhibitor",
    "target": "CASP3 | CDC25A | CDC25B",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "PI-103",
    "brd_id": "BRD-K67868012-003-01-5",
    "sig_id": "CPC006_HCC515_24H:BRD-K67868012-003-01-5:11.1",
    "score": -4.5155,
    "pvalue": 0.00322618065325763,
    "qvalue": 0.292575571944643,
    "zscore": 1.812518259583613,
    "cell_line": "HCC515",
    "dose": "11.1",
    "time": "24H",
    "moa": "mTOR inhibitor | PI3K inhibitor",
    "target": "MTOR | PIK3CA | PIK3CB | PIK3CD | PIK3CG | PRKDC",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "calcipotriol",
    "brd_id": "BRD-K56429665-001-03-9",
    "sig_id": "CPC005_PC3_24H:BRD-K56429665-001-03-9:10",
    "score": -4.4439,
    "pvalue": 0.0034432332381302,
    "qvalue": 0.292575571944643,
    "zscore": 1.8042290648008414,
    "cell_line": "PC3",
    "dose": "10",
    "time": "24H",
    "moa": "vitamin D receptor agonist",
    "target": "VDR",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "PP-2",
    "brd_id": "BRD-K95785537-001-09-0",
    "sig_id": "CPC002_PC3_6H:BRD-K95785537-001-09-0:10",
    "score": -4.4316,
    "pvalue": 0.00374937194090034,
    "qvalue": 0.292575571944643,
    "zscore": 1.8266825286110677,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "SRC inhibitor",
    "target": "ABL1 | LCK | RIPK2 | SRC",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "WZ-3146",
    "brd_id": "BRD-K73293050-001-01-5",
    "sig_id": "CPC014_ASC_24H:BRD-K73293050-001-01-5:10",
    "score": -4.227,
    "pvalue": 0.00333338656690784,
    "qvalue": 0.292575571944643,
    "zscore": 1.7064153864450105,
    "cell_line": "ASC",
    "dose": "10",
    "time": "24H",
    "moa": "EGFR inhibitor",
    "target": "EGFR",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "indirubin-3-monoxime",
    "brd_id": "BRD-K19136521-001-03-0",
    "sig_id": "CPC004_PC3_6H:BRD-K19136521-001-03-0:10",
    "score": -4.2237,
    "pvalue": 0.00416001111767976,
    "qvalue": 0.292575571944643,
    "zscore": 1.7740039676326338,
    "cell_line": "PC3",
    "dose": "10",
    "time": "6H",
    "moa": "CDK inhibitor | glycogen synthase kinase inhibitor",
    "target": "CCNE1 | CDK1 | CDK2 | CDK4 | CDK5 | CDK5R1 | CDK9 | GSK3B | LCK | LRRK1 | LRRK2",
    "phase": "",
    "confidence": "low"
  },
  {
    "drug_name": "trichostatin-a",
    "brd_id": "BRD-K68202742-001-06-6",
    "sig_id": "CPC012_MCF7_6H:BRD-K68202742-001-06-6:10",
    "score": -4.1337,
    "pvalue": 0.00382897419013385,
    "qvalue": 0.292575571944643,
    "zscore": 1.7103013251866632,
    "cell_line": "MCF7",
    "dose": "10",
    "time": "6H",
    "moa": "HDAC inhibitor",
    "target": "HDAC1 | HDAC10 | HDAC2 | HDAC3 | HDAC4 | HDAC5 | HDAC6 | HDAC7 | HDAC8 | HDAC9",
    "phase": "",
    "confidence": "low"
  }
]